U.S. Rejects Novartis Painkiller

By Hans Schoemaker and Jeanne Whalen

Novartis AG said the U.S. Food and Drug Administration rejected its painkiller Prexige in a decision that had been expected after the drug was withdrawn from the Australian market due to side effects.